High-Dose fungus fighter tested in Life-Threatening infections
NCT ID NCT00467883
Summary
This study tested whether a high dose of the antifungal medicine Ambisome could effectively treat zygomycosis, a rare but serious fungal infection. The trial involved 40 patients with confirmed infections and measured how well they responded to treatment over four weeks. Researchers also tracked side effects and survival rates to understand the treatment's safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ZYGOMYCOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker - Service des Maladies Infectieuses et Tropicales
Paris, 75015, France
-
Necker Hospital
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.